Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Abstract Background Mother-to-child transmission (MTCT) is one of the main routes of transmission of HBV, and previous studies focused on the efficacy and safety of nucleoside analogues (NAs) in preventing MTCT. There are limited data on virologic changes of chronic hepatitis B (CHB) patients after...

Bibliografske podrobnosti
Main Authors:	Qiao Tang, Chunrui Wang, Hu Li, Zhiwei Chen, Li Zhang, Jing Zhang, Xiaoqing Liu, Yunling Xue, Yue Qiu, Mingli Peng, Yi Zeng, Peng Hu
Format:	Article
Jezik:	English
Izdano:	BMC 2025-02-01
Serija:	Virology Journal
Teme:	Mother-to-child transmission ALT abnormal Liver fibrosis Virologic response Treatment discontinuation
Online dostop:	https://doi.org/10.1186/s12985-025-02632-x

Podobne knjige/članki

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
od: Luisa Roade, et al.
Izdano: (2023-10-01)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
od: Ying Yan, et al.
Izdano: (2022-11-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
od: Jing Zhao, et al.
Izdano: (2023-03-01)

Deteksi HBsAg dan HBeAg dalam Saliva Pengidap Virus Hepatitis B
od: Riemawati A. Lesmana
Izdano: (2015-10-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
od: Tung-Hung Su, et al.
Izdano: (2013-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
od: Chih-Chien Yao, et al.
Izdano: (2017-05-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
od: Crozier Sarah, et al.
Izdano: (2008-04-01)

Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
od: Dimitri Loureiro, et al.
Izdano: (2019-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
od: Anouar Teriaky, et al.
Izdano: (2013-01-01)

Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy
od: Haiying Luo, et al.
Izdano: (2023-07-01)

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
od: Chen-Hsuan Wu, et al.
Izdano: (2017-04-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
od: Taqwa Hashim, et al.
Izdano: (2023-12-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
od: Yifei Guo, et al.
Izdano: (2023-02-01)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
od: Teresa Broquetas, et al.
Izdano: (2017-01-01)

Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
od: Fatima A Ahmed, et al.
Izdano: (2019-01-01)

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women
od: Erry Gumilar Dachlan, et al.
Izdano: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
od: Cheng-Yuan Peng, et al.
Izdano: (2015-04-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
od: Jia-Feng Wu, et al.
Izdano: (2024-05-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
od: Shengxia Yin, et al.
Izdano: (2023-12-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
od: Michel Bazinet, et al.
Izdano: (2022-08-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
od: Stijn Van Hees, et al.
Izdano: (2019-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
od: Romina Salpini, et al.
Izdano: (2020-01-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
od: Zhan Zeng, et al.
Izdano: (2023-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
od: Yan Peng, et al.
Izdano: (2025-01-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
od: Meng Zhuo Cao, et al.
Izdano: (2018-06-01)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
od: Gao F, et al.
Izdano: (2021-10-01)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
od: Elisabetta Loggi, et al.
Izdano: (2013-01-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
od: Jack Bee Chook, et al.
Izdano: (2019-09-01)

Possible immunochemical pattern of anti-HCV, HBeAg, HBsAg HBeAb, and HIV-1 p24 in newly infected Mycobacterium pulmonary tuberculosis patients
od: Mathew Folaranmi Olaniyan, et al.
Izdano: (2019-01-01)

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
od: Won-Mook Choi, et al.
Izdano: (2022-05-01)

Correlation of fulminant hepatitis B, HBeAg start-codon depletions and escape mutations in the 2nd loop of the HBsAg a-determinant
od: T. Michler, et al.
Izdano: (2014-04-01)

Prevalence of HBe Ag and LFT Survey in HBsAg Positive Blood Donors in Kerman
od: M.J Zahedi, et al.
Izdano: (2003-07-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
od: K. V. Zhdanov, et al.
Izdano: (2014-09-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
od: Ayub Al Mamun, et al.
Izdano: (2013-01-01)

Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
od: Menghui Duan, et al.
Izdano: (2024-07-01)

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
od: Yong Poovorawan, et al.
Izdano: (2012-07-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
od: Jian Wang, et al.
Izdano: (2024-12-01)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
od: Tai-Long Chien, et al.
Izdano: (2016-01-01)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Izdano: (2006-01-01)

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention
od: Qiao Tang, et al.
Izdano: (2024-12-01)